Skip to content

Comparison of efficacy of Tacrolimus 0.03% ointment with Mometason ointment in treatment of pediatric Atopic Dermatitis

Comparison of efficacy of Tacrolimus 0.03% ointment with Mometason ointment in treatment of pediatric Atopic Dermatitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091012002581N6
Enrollment
30
Registered
2019-11-25
Start date
2019-12-06
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis. Atopic dermatitis

Interventions

Intervention 1: Intervention group: Topical Tacrolimus 0.03% ointment.in the intervention group,15 childs with Atopic Dermatitis will be treated with Tacrolimus 0.03% ointment every 12 hours for 6 wee

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children 2-10 years old. Children whose lesion are up to 5 cm in size. Children with limb lesions. Children whose parents declare their full written informed consent to participate in this study. Children with mild to moderate lesions.

Exclusion criteria

Exclusion criteria: Children who have other skin conditions at the same time. Children whose skin lesions are infected.

Design outcomes

Primary

MeasureTime frame
Atopic Dermatitis lesions severity index. Timepoint: Weeks 0, 3, 6. Method of measurement: Observation.;Size of Atopic Dermatitis lesion. Timepoint: Weeks 0, 3, 6. Method of measurement: Ruler measurement.;Patient symptoms. Timepoint: Weeks 0, 3, 6. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Possible complications. Timepoint: Weeks 0, 3, 6. Method of measurement: Observation _ questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamide Herizchi Ghadim

Tabriz University of Medical Sciences

Drherizchi@yahoo.com+98 41 8236 3549

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026